🔗 Share this article

An underground market for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on messaging platforms, based on recent findings.

Experimental Drug Gaining Popularity Via Social Media

The experimental drug, which remains in research studies, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with numerous of members share comparison images, injection guides and claims of next-day British shipping. Sellers promote the drug there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Professionals Voice Worries

However, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the UK is worrisome and could result in users administering products of unknown origin.

Several professionals stated the demand for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or prison.

Service Response and Material Removal

According to the social media company, the platform has removed problematic material and prohibited related hashtags and query recommendations. The company stated it was dedicated to keeping the service safe and allocating resources in strengthening compliance measures.

Digital Marketplace Operations

Research also found groups with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, filled with images of weight loss, glowing testimonials and detailed instructions for mixing or administering at home.

After minutes of joining one community, a vendor posted WhatsApp details, where most transactions take place. The seller sent an instruction manual and guaranteed shipping within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about weight, medical conditions or previous experience.

Product Details and Pricing

Within these groups, posts display black plastic packages with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When questioned how long a injector should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it actively monitored dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they can’t verify. Even if the research behind this drug is valid, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in interest to current price rises for authorized slimming drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose patients to potentially significant health risks”.